1990
DOI: 10.1016/0014-4894(90)90012-2
|View full text |Cite
|
Sign up to set email alerts
|

Schistosoma japonicum: An ultraviolet-attenuated cercarial vaccine applicable in the field for water buffaloes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
39
0

Year Published

1993
1993
2011
2011

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 57 publications
(40 citation statements)
references
References 16 publications
1
39
0
Order By: Relevance
“…Furthermore, protection against schistosome parasites appears to be species specific (124,150) and, in the case of the Chinese and Philippine strains of S. japonicum, even strain specific (15,124). UV-attenuated S. japonicum cercarial vaccines have been tested successfully in buffaloes (222) and in pigs (163) under field conditions in China, but due to the difficulty and impracticality of producing quality-controlled, reproducible batches of these vaccines on a large scale and the associated safety considerations, they are clearly not suitable for use in humans or for wide veterinary application. As a result, considerable attention has focused on investigating the protective mechanisms of the anti-schistosome immune response and identifying relevant parasite antigens that may be involved in inducing protective immune responses, with a view to developing a recombinant synthetic-peptide-based (164) or DNA (4) vaccine.…”
Section: Vaccine Development Rationalementioning
confidence: 99%
“…Furthermore, protection against schistosome parasites appears to be species specific (124,150) and, in the case of the Chinese and Philippine strains of S. japonicum, even strain specific (15,124). UV-attenuated S. japonicum cercarial vaccines have been tested successfully in buffaloes (222) and in pigs (163) under field conditions in China, but due to the difficulty and impracticality of producing quality-controlled, reproducible batches of these vaccines on a large scale and the associated safety considerations, they are clearly not suitable for use in humans or for wide veterinary application. As a result, considerable attention has focused on investigating the protective mechanisms of the anti-schistosome immune response and identifying relevant parasite antigens that may be involved in inducing protective immune responses, with a view to developing a recombinant synthetic-peptide-based (164) or DNA (4) vaccine.…”
Section: Vaccine Development Rationalementioning
confidence: 99%
“…In domestic animals (artiodactyl), the RA S. japonicum vaccine was always able to induce high levels of protection, and the protection exceeded 60% in pig and cattle. But few have involved the possible underlying mechanisms in theses studies except some suggested the involvement of antibody [15], [16], [17], [18], [19]. An understanding of protective human immune mechanisms is essential to engineer an efficacious vaccine formula for human schistosomiasis [5], We need first to understand the immunological responses elicited by RA cercariae, which could pave the way for the human correlated studies.…”
Section: Introductionmentioning
confidence: 99%
“…The studies of testing irradiation-attenuated cercariae as a possible vaccine against schistosomiasis were performed more than 50 years ago (Villella et al 1961;Szumlewicz and Olivier 1963). Many studies have shown that administration of live irradiation-attenuated cercariae to a large range of laboratory animals Shi et al 1990Shi et al , 1993, including nonhuman primates (Shi et al 1993;Eberl et al 2000;Torben and Hailu 2007), could provide 70-90% protection against experimental S. mansoni and Schistosoma japonicum infections. But due to the limit of cercariae supply and transportation and ethical implications for using living parasites, it is not feasible to use irradiated cercariae as vaccine in humans.…”
Section: Introductionmentioning
confidence: 99%